Evidence map›Paper›PMID 10899116›Full record

ArticleThe EMBO journal2000

Identification and characterization of a highly conserved calcineurin binding protein, CBP1/calcipressin, in Cryptococcus neoformans.

J Görlach, D S Fox, N S Cutler, G M Cox, J R Perfect, J Heitman

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 170 citations in OpenAlex.

  1. Trial
  2. Leveraging CRISPR-Cas13d in an inducible knockdown system to interrogatebioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

J GörlachDepartments of Genetics, Medicine, Microbiology, Pharmacology and Cancer Biology, and The Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.
D S Fox
N S Cutler
G M Cox
J R Perfect
J Heitman
Duke Medical Center · USDuke University Hospital · USDuke University · US

Funding

Ruth L. Kirschstein National Research Service Award (NRSA)- T32T32AI007392 · NIAID · DUKE UNIVERSITY · PI Amy Lynn Corneli, Guido Ferrari · 1990 to 2026
$9.8M
ROLE OF CALCINEURIN IN C. NEOFORMANS MATING AND FRUITINGR01AI039115 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH · 1997 to 2025
$6.7M
Genetics of Cryptococcus sexual reproductionR37AI039115 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH · 2011 to 2020
$4.9M
SIGNAL TRANSDUCTION PATHWAYS REGULATING VIRULENCEP01AI044975 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 1999 to 2003
$3.4M
Role of Calcineurin in Fungal VirulenceR01AI042159 · NIAID · DUKE UNIVERSITY · PI HEITMAN, JOSEPH · 1998 to 2009
$2.5M
NIAID NIH HHS 5T32AI07392NIAID NIH HHS P01 AI044975NIAID NIH HHS R01 AI039115NIAID NIH HHS R01 AI042159NIAID NIH HHS R01AI39115NIAID NIH HHS R01AI42159NIAID NIH HHS R37 AI039115NIAID NIH HHS T32 AI007392
6 · The paper itself

Abstract

Calcineurin is the conserved target of the immunosuppressants cyclosporin A and FK506. Using the yeast two-hybrid system, we identified a novel calcineurin binding protein, CBP1, from the pathogenic fungus Cryptococcus neoformans. We show that CBP1 binds to calcineurin in vitro and in vivo, and FKBP12-FK506 inhibits CBP1 binding to calcineurin. Cryptococcus neoformans cbp1 mutant strains exhibit modest defects in growth under stress conditions and virulence, similar to but less severe than the phenotypes of calcineurin mutants. Saccharomyces cerevisiae mutants lacking the CBP1 homolog RCN1 are, like calcineurin mutants, sensitive to lithium cation stress. CBP1 shares a central peptide sequence motif, SPPxSPP, with related proteins in S.CEREVISIAE:, Schizosaccharomyces pombe, Drosophila melanogaster, Caenorhabditis elegans and humans, and peptides containing this motif altered calcineurin activity in vitro. Interestingly, the human CBP1 homolog DSCR1 is encoded by the Down's syndrome candidate region interval on chromosome 21, is highly expressed in the heart and central nervous system, and may play a role in calcineurin functions in heart development, neurite extension and memory.

Indexed as

Conserved SequenceCryptococcus neoformansSaccharomyces cerevisiae ProteinsAmino Acid MotifsAmino Acid SequenceAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCalcineurinCalcineurin InhibitorsCatalytic DomainDNA-Binding ProteinsElectrophoresis, Polyacrylamide GelFungal ProteinsHumansHydrogen-Ion ConcentrationImmunophilinsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCalcineurinCalcineurin InhibitorsCBF1 protein, S cerevisiaeDNA-Binding ProteinsFungal ProteinsImmunophilinsSaccharomyces cerevisiae ProteinsTacrolimus Binding Proteins

Identifiers

PMID10899116
PMCPMC313974
OpenAlexW2145966324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.